The role of economic evaluation in regulating the prices of innovative medicines protected by patents (notice n° 551539)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01097cam a2200157 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121120423.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wittwer, Jérôme |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | The role of economic evaluation in regulating the prices of innovative medicines protected by patents |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2018.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 51 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The purpose of this contribution is to return to the theoretical role of the economic valuation of innovative medicines within the framework of the regulation of the pharmaceutical market based on patent protection for innovations. After a review of the incentive mechanisms of patent market regulation, the role of economic evaluation in this regulatory framework is clarified. The specific context of fixing prices for medicine in France and the role of economic evaluation are studied at the end of the article. |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Revue française des affaires sociales | - | 3 | 2018-11-07 | p. 147-159 | 0035-2985 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-revue-francaise-des-affaires-sociales-2018-3-page-147?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-revue-francaise-des-affaires-sociales-2018-3-page-147?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux